← Leaderboards
Eric Vallabh Minikel
Broad Institute, Inc.
$8,891,123
Attributed
$9,487,544
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,487,544 · 9
By mechanism
U19$4,678,618 · 2
U01$1,705,301 · 1
R01$1,263,559 · 1
R33$792,965 · 1
R21$481,250 · 1
R61$399,878 · 1
Top collaborators
- Sonia Minikel Vallabh3 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Sonia Minikel Vallabh$10,218,926
- Benjamin E Deverman$18,180,267
Others in their field
Top investigators on “Prion Diseases”
- Stanley B Prusiner · University Of California San Francisco$42,326,866
- Claudio Soto · University Of Texas Medical Br Galveston$31,398,981
- Glenn C Telling · Colorado State University$23,470,323
- David A Harris · Washington University$22,508,580
- Stephen M Strittmatter · Yale University$20,347,521
- Witold K Surewicz · Case Western Reserve University$19,852,886
Research focus
Prion DiseasesNeurodegenerative DisordersPrionsProteinsPrp GeneBrainPharmaceutical PreparationsResponseAnimalsDoseMolecular ConformationGeneticBiological MarkersLeadCellsHumanized MouseSmall Interfering RnaPharmacologicSymptomsLifeHuman Cell LineAntisense OligonucleotidesPreventNeuropathology
Grant awards (19)
Biomarkers and Mechanisms of PrP Misfolding, Mutation, and Deficiency$585,539
R01 · FY2025 · NS · contact PI
Research Project 3$534,220
U19 · FY2025 · NS · contact PI
Prion Clearance and Treatment of Recalcitrant Prion Strains Through Deep PrP Suppression$481,250
R21 · FY2025 · NS · contact PI
Research Project 2$408,426
U19 · FY2025 · NS · contact PI
Regulatory Consulting to Support Advancement of a Divalent siRNA for Prion Disease$98,280
U01 · FY2025 · NS · contact PI
Research Project 3$1,053,304
U19 · FY2024 · NS · contact PI
Research Project 2$897,403
U19 · FY2024 · NS · contact PI
Advancement of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease$806,536
U01 · FY2024 · NS · contact PI
Biomarkers and mechanisms of PrP misfolding, mutation, and deficiency$678,020
R01 · FY2024 · NS · contact PI
Research Project 3$1,028,978
U19 · FY2023 · NS · contact PI
Advancement of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease$800,485
U01 · FY2023 · NS · contact PI
Research Project 2$756,287
U19 · FY2023 · NS · contact PI
Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease$387,675
R33 · FY2023 · NS · contact PI
Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease$405,290
R33 · FY2022 · NS · contact PI
Identifying the genetic basis of variably protease-sensitive prionopathy$66,800
R03 · FY2022 · NS · contact PI
Development of prion protein-lowering divalent siRNA therapy for prion disease$399,878
R61 · FY2021 · NS · contact PI
Developing in vitro assays to identify small molecules that inhibit human prions$26,111
F31 · FY2018 · AI · contact PI
Developing in vitro assays to identify small molecules that inhibit human prions$36,765
F31 · FY2017 · AI · contact PI
Developing in vitro assays to identify small molecules that inhibit human prions$36,297
F31 · FY2016 · AI · contact PI